BCBA/TEM (BCBA/TEM)

Buenos Aires Stock Exchange: BCBA/TEM · ARS

ARS 10,080

+744.94 (+8.0%)· Recorded snapshot

Market cap	20T
Revenue (ttm)	2.1T
Net income (ttm)	-376.9B
EPS (ttm)	-ARS 184
Volume	37,233

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1T
Net income (ttm): -376.9B
EPS (ttm): -ARS 184
Market cap: 20T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-67.4

P25 n/aP50 n/aP75 n/a

ROIC-11.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/TEM indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-02
Employees	3,800
Employees change	1,400
Employees growth	58.33%
Enterprise value	ARS 21T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Health Information Services
Is primary listing	No
ISIN number	AR0520934156
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	ARS 20T
Next earnings date	2026-11-02
Price	ARS 10,080.00
Price currency	ARS
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-27
Symbol	bcba/TEM
Website	https://www.tempus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.82%
EV/Sales	9.53x
FCF / EV yield	-1.86%
FCF yield	-1.95%
P/B ratio	30.38x
P/S ratio	9.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-19.69%
EBITDA margin	-14.14%
Gross margin	63.98%
Operating margin	-19.69%
Pretax margin	-18.15%
Profit margin	-17.77%
Profit per employee	ARS -99.2M
Profitable quarters	1
Revenue per employee	ARS 558.3M
ROA	-8.83%
ROA (5Y)	-27.91%
ROCE	-14.28%
ROE	-67.44%
ROIC	-11.55%
SBC / revenue	13%
Tax / revenue	-0.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
Gross profit growth	58.47%
Gross profit growth (Q)	26.38%
Gross profit growth 3Y	91.63%
Net income growth quarters	1
Net income growth years	1
Revenue growth	50.43%
Revenue growth (Q)	21.57%
Revenue growth (QoQ)	9.87%
Revenue growth 3Y	64.68%
Revenue growth quarters	10
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -38.2B
Depreciation and amortization	ARS 122.3B
EBIT	ARS -417.7B
EBITDA	ARS -299.9B
EPS	ARS -183.78
Financing cash flow	ARS 1T
Free cash flow	ARS -390B
Free cash flow minus SBC	ARS -665.7B
Gross profit	ARS 1.4T
Income taxes	ARS -8.1B
Investing cash flow	ARS -50.6B
Net borrowing	ARS 878B
Net cash flow	ARS 616.7B
Net income	ARS -376.9B
Operating cash flow minus SBC	ARS -627.5B
Operating income	ARS -417.7B
Revenue	ARS 2.1T
Stock-based compensation	ARS 275.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.71
Book value per share	ARS 3,660.82
Debt / equity	3.25
Goodwill	ARS 723.2B
Interest coverage	-5.1
Long-term assets	ARS 1.5T
Long-term liabilities	ARS 2.2T
Net cash (debt)	ARS -930.6B
Net cash / market cap	-4.65%
Net debt / equity	1.41
Piotroski F-Score	3
Property, plant and equipment	ARS 230.2B
Shareholders' equity	ARS 659.2B
Tangible book value	ARS -529.6B
Tangible book value per share	ARS -2,941.11
Total assets	ARS 3.5T
Total cash	ARS 1.2T
Total debt	ARS 2.1T
Total liabilities	ARS 2.8T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.72
Current assets	ARS 2T
Current liabilities	ARS 602.2B
Current ratio	3.3
Inventory turnover	10.2
Net working capital	ARS 141.6B
Quick ratio	3.01
Working capital	ARS 1.3T
Working capital turnover	3,770.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.09%
Shareholder yield	-5.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 7,347.07
1D price change	7.98%
1M price change	-11.97%
1M total return	-11.97%
1W price change	15.2%
1W total return	15.2%
1Y price change	-13.62%
1Y return CAGR	-13.63%
1Y total return	-13.62%
20-day SMA	ARS 9,645.75
200-day SMA	ARS 7,335.40
3M price change	77.78%
3M total return	77.78%
50-day SMA	ARS 9,324.20
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 12,100.00
52-week high date	2025-10-27
52-week low	ARS 5,165.00
52-week low date	2026-03-30
6M price change	56.28%
6M total return	56.28%
All-time high	ARS 13,350.00
All-time high date	2025-10-08
All-time low	ARS 5,160.00
All-time low date	2025-05-28
Average true range (ATR)	ARS 678.26
Average volume	9.2K
Change from 52-week high	-16.69%
Change from 52-week low	95.16%
Change from all-time high	-24.49%
Change from all-time low	95.35%
Change from open	6.78%
Day's gap	1.12%
Dollar volume	ARS 375.3M
High price	ARS 10,080.00
Low price	ARS 9,310.00
Monthly RSI	56.29
Open price	ARS 9,440.00
Position in 52-week range	100%
Previous close	ARS 9,335.00
Price vs 150-day SMA	37.2%
Price vs 20-day SMA	4.5%
Price vs 200-day SMA	37.42%
Price vs 50-day SMA	8.11%
Relative volume	4.05
RSI	56.26
Sharpe ratio	0.16
Sortino ratio	0.34
Volume	37.2K
Weekly RSI	58.41
YTD price change	31.77%
YTD total return	31.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	116.3M
Shares change (QoQ)	1.92%
Shares change (YoY)	5.09%
Shares held by insiders	34.64%
Shares held by institutions	57.22%
Short ratio	3.7 days

Deeper analysis on BCBA/TEM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/TEM report

Is a complete BCBA/TEM research report available?

No complete published report is available for bcba/TEM (BCBA/TEM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/TEM (BCBA/TEM)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/TEM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/TEM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/TEM

Frequently asked questions